SlideShare a Scribd company logo
1 of 28
Sympathomimetics
Dr.M.Usman Khalid
DPT,MS-NMPT
Sympathomimetics
O A drug that mimics stimulation of the
sympathetic autonomic nervous system.
CLASSIFICATION
Mode of Action
O Sympathomimetic agonists may directly
activate their adrenoceptors, or they may
act indirectly to increase the concentration
of endogenous catecholamine transmitter
in the synapse.
Types of adrenoceptors, some of the peripheral
tissues in which they are found, and their
major effects
CHEMISTRY &
PHARMACOKINETICS
O The endogenous adrenoceptor agonists
(epinephrine, norepinephrine, and
dopamine) are catecholamines and are
rapidly metabolized by COMT and MAO.
O If used as drugs, these adrenoceptor
agonists are relatively inactive by the oral
route and must be given parenterally.
O Short duration of action.
MECHANISMS OF ACTION
O A. Alpha-Receptor Effects: Alpha-
receptor effects are mediated primarily by
the trimeric coupling protein Gq. When Gq
is activated, the alpha moiety of this
protein activates the enzyme
phospholipase C, resulting in the release
of inositol-1,4,5-trisphosphate (IP3) and
diacylglycerol (DAG) from membrane
lipids.
B. Beta-Receptor Effects
O All β receptors (β1, β2, and β3) stimulate
adenylyl cyclase via the coupling protein
Gs, which leads to an increase in cyclic
adenosine monophosphate (cAMP)
concentration in the cell.
C. Dopamine-Receptor
Effects
O Dopamine D1 receptors activate adenylyl
cyclase via Gs and increase cAMP in
neurons and vascular smooth muscle.
O Dopamine D2 receptors are more
important in the brain but probably also
play a significant role as presynaptic
receptors on peripheral nerves.
O These receptors reduce the synthesis of
cAMP via Gi.
ORGAN SYSTEM EFFECTS
O A. Central Nervous System: Sympathomimetics
that do enter the CNS (eg, amphetamines,
cocaine) have a spectrum of stimulant effects,
beginning with mild alerting or reduction of fatigue
and progressing to anorexia, euphoria, and
insomnia.
O Repeated dosing of amphetamines results in the
rapid development of tolerance and dependence.
O Very high doses of amphetamines lead to marked
anxiety or aggressiveness, paranoia, and, less
commonly, seizures.
O Overdoses of cocaine very commonly result in
seizures.
B. Eye
O The smooth muscle of the pupillary dilator
responds to topical phenylephrine and
similar α agonists with contraction and
mydriasis.
O Accommodation is not significantly
affected.
C. Bronchi
O The smooth muscle of the bronchi relaxes
markedly in response to β2 agonists, eg,
isoproterenol and albuterol. These
agents are the most efficacious and
reliable drugs for reversing
bronchospasm.
D. Gastrointestinal Tract
O The gastrointestinal tract is well endowed
with both α and β receptors, located both
on smooth muscle and on neurons of the
enteric nervous system.
O Activation of either α or β receptors leads
to relaxation of the smooth muscle.
Alpha2 agonists may also decrease salt
and water secretion into the intestine.
E. Genitourinary Tract
O The genitourinary tract contains α receptors in
the bladder trigone and sphincter area; these
receptors mediate contraction of the
sphincter.
O In men, α1 receptors mediate prostatic
smooth muscle contraction.
O Sympathomimetics are sometimes used to
increase sphincter tone.
O Beta2 agonists may cause significant uterine
relaxation in pregnant women near term, but
the doses required also cause significant
tachycardia.
F. Vascular System
O Different vascular beds respond
differently, depending on their dominant
receptor type:
O 1. Alpha1 agonists—
O Alpha1 agonists (eg, phenylephrine)
contract vascular smooth muscle,
especially in skin and splanchnic blood
vessels, and increase peripheral vascular
resistance and venous pressure. Because
these drugs increase blood pressure, they
often evoke a compensatory reflex
bradycardia.
O 2. Alpha2 agonists—
O Alpha2 agonists (eg, clonidine) cause
vasoconstriction when administered
intravenously or topically (eg, as a nasal
spray), but when given orally they
accumulate in the CNS and reduce
sympathetic outflow and blood pressure.
O 3. Beta agonists—Beta2 agonists (eg,
albuterol, metaproterenol, terbutaline)
and nonselective β agonists (eg,
isoproterenol) cause significant reduction
in arteriolar tone in the skeletal muscle
vascular bed and can reduce peripheral
vascular resistance and arterial blood
pressure.
O Beta1 agonists have relatively little effect
on vessels.
O 4. Dopamine—
O Dopamine causes vasodilation in the
splanchnic and renal vascular beds by
activating D1 receptors.
O This effect can be useful in the treatment
of renal failure associated with shock.
O At higher doses, dopamine activates β
receptors in the heart and elsewhere; at
still higher doses, α receptors are
activated.
G.Heart
O The heart is well supplied with β1 and β2
receptors.
O The β1 receptors predominate in some
parts of the heart; both β1 and β2
receptors mediate increased rate of
cardiac pacemakers (normal and
abnormal), increased atrioventricular node
conduction velocity, and increased cardiac
force.
Net Cardiovascular Actions
O Sympathomimetics with both α and β1 effects
(eg, norepinephrine) may cause a reflex
increase in vagal outflow because they
increase blood pressure and evoke the
baroreceptor reflex.
O This reflex vagal effect may dominate any
direct beta effects on the heart rate, so that a
slow infusion of norepinephrine typically
causes increased blood pressure and
bradycardia .
O If the reflex is blocked (eg, by a ganglion
blocker or antimuscarinic drug),
norepinephrine will cause a direct β1-
mediated tachycardia.
Metabolic and Hormonal
Effects
O Beta1 agonists increase renin secretion.
O Beta2 agonists increase insulin secretion.
O All β agonists appear to stimulate lipolysis
via the β3 receptor.
CLINICAL USES
A. Anaphylaxis
O Epinephrine is the drug of choice for the
immediate treatment of anaphylactic shock.
B. Central Nervous System
O The phenylisopropylamines such as
amphetamine are widely used and abused
for their CNS effects. Legitimate indications
include narcolepsy and, with appropriate
adjuncts, weight reduction.
O Cocaine is abused for its mood-elevating
effect. These drugs have a high addiction
liability.
C. Eye
O The α agonists, especially phenylephrine
and tetrahydrozoline, are often used to
reduce the conjunctival itching and
congestion caused by irritation or allergy.
O Newer α2 agonists are in current use for
glaucoma and include apraclonidine and
brimonidine.
D. Bronchi
O The β agonists, especially the β2-
selective agonists, are drugs of choice in
the treatment of acute asthmatic
bronchoconstriction.
O The short-acting β2-selective agonists
(eg, albuterol, metaproterenol,
terbutaline) are not recommended for
prophylaxis, but they are safe and
effective and may be lifesaving in the
treatment of acute bronchospasm.
E. Cardiovascular Applications
1. Conditions in which an increase in
blood flow is desired: Beta1 agonist
2. Conditions in which a decrease in
blood flow or increase in blood pressure
is desired: Alpha1 agonists
3. Conditions in which acute cardiac
stimulation is desired: Epinephrine
O Genitourinary Tract:
Beta2 agonists (ritodrine, terbutaline) are
sometimes used to suppress premature
labor, but the cardiac stimulant effect may
be hazardous to both mother and fetus.
TOXICITY
O Excessive vasoconstriction
O Cardiac arrhythmias
O myocardial infarction
O hemorrhagic stroke
O Pulmonary edema or hemorrhage
Sympathomimetics

More Related Content

What's hot

Seretonin (5HT) and Its Antagonists Pharmacology
Seretonin (5HT) and Its Antagonists PharmacologySeretonin (5HT) and Its Antagonists Pharmacology
Seretonin (5HT) and Its Antagonists PharmacologyPranatiChavan
 
Serotonin receptors
Serotonin receptorsSerotonin receptors
Serotonin receptorsFarazaJaved
 
Sympatholytics
SympatholyticsSympatholytics
SympatholyticsSmita Jain
 
Sympathomimetics or Adrenergic Agonists (Introduction, Classification, Adenor...
Sympathomimetics or Adrenergic Agonists (Introduction, Classification, Adenor...Sympathomimetics or Adrenergic Agonists (Introduction, Classification, Adenor...
Sympathomimetics or Adrenergic Agonists (Introduction, Classification, Adenor...Ahmad Naeem
 
neurotransmitter gaba
neurotransmitter gabaneurotransmitter gaba
neurotransmitter gabaRuksana.c.a
 
Adrenergic receptors and its modulators
Adrenergic receptors and its modulatorsAdrenergic receptors and its modulators
Adrenergic receptors and its modulatorsDr. Imran Zaheer
 
Serotonin Pharmacology (5-HT) [Neurotransmitter]
Serotonin Pharmacology (5-HT) [Neurotransmitter]Serotonin Pharmacology (5-HT) [Neurotransmitter]
Serotonin Pharmacology (5-HT) [Neurotransmitter]Megh Vithalkar
 
Sympathomimetics and blockers
Sympathomimetics and blockersSympathomimetics and blockers
Sympathomimetics and blockersDr Pralhad Patki
 
Neurohumoral Transmission in central nervous system
Neurohumoral Transmission in central nervous systemNeurohumoral Transmission in central nervous system
Neurohumoral Transmission in central nervous systemSONALPANDE5
 
Parasympathomimetic drugs
Parasympathomimetic drugs Parasympathomimetic drugs
Parasympathomimetic drugs Dr Pralhad Patki
 
Gaba ppt
Gaba pptGaba ppt
Gaba pptAya Ali
 
Non adrenergic and Non cholinergic transmission
Non adrenergic and Non cholinergic transmission Non adrenergic and Non cholinergic transmission
Non adrenergic and Non cholinergic transmission E Poovarasan
 

What's hot (20)

Sympathomimetics
SympathomimeticsSympathomimetics
Sympathomimetics
 
5-HT Pharmacology - drdhriti
5-HT Pharmacology - drdhriti5-HT Pharmacology - drdhriti
5-HT Pharmacology - drdhriti
 
Seretonin (5HT) and Its Antagonists Pharmacology
Seretonin (5HT) and Its Antagonists PharmacologySeretonin (5HT) and Its Antagonists Pharmacology
Seretonin (5HT) and Its Antagonists Pharmacology
 
Serotonin receptors
Serotonin receptorsSerotonin receptors
Serotonin receptors
 
Sympatholytics
SympatholyticsSympatholytics
Sympatholytics
 
Neurotransmitter - Dopamine
Neurotransmitter - DopamineNeurotransmitter - Dopamine
Neurotransmitter - Dopamine
 
Sympathomimetics or Adrenergic Agonists (Introduction, Classification, Adenor...
Sympathomimetics or Adrenergic Agonists (Introduction, Classification, Adenor...Sympathomimetics or Adrenergic Agonists (Introduction, Classification, Adenor...
Sympathomimetics or Adrenergic Agonists (Introduction, Classification, Adenor...
 
neurotransmitter gaba
neurotransmitter gabaneurotransmitter gaba
neurotransmitter gaba
 
Glutamate
GlutamateGlutamate
Glutamate
 
Adrenergic receptors and its modulators
Adrenergic receptors and its modulatorsAdrenergic receptors and its modulators
Adrenergic receptors and its modulators
 
Serotonin Pharmacology (5-HT) [Neurotransmitter]
Serotonin Pharmacology (5-HT) [Neurotransmitter]Serotonin Pharmacology (5-HT) [Neurotransmitter]
Serotonin Pharmacology (5-HT) [Neurotransmitter]
 
Sympathomimetics and blockers
Sympathomimetics and blockersSympathomimetics and blockers
Sympathomimetics and blockers
 
Acetylcholine ppt
Acetylcholine pptAcetylcholine ppt
Acetylcholine ppt
 
Neurohumoral Transmission in central nervous system
Neurohumoral Transmission in central nervous systemNeurohumoral Transmission in central nervous system
Neurohumoral Transmission in central nervous system
 
Parasympathomimetic drugs
Parasympathomimetic drugs Parasympathomimetic drugs
Parasympathomimetic drugs
 
Parasympatholytic drugs
Parasympatholytic drugsParasympatholytic drugs
Parasympatholytic drugs
 
Gaba ppt
Gaba pptGaba ppt
Gaba ppt
 
Non adrenergic and Non cholinergic transmission
Non adrenergic and Non cholinergic transmission Non adrenergic and Non cholinergic transmission
Non adrenergic and Non cholinergic transmission
 
Seminar on histamine
Seminar on histamineSeminar on histamine
Seminar on histamine
 
Cotransmission
CotransmissionCotransmission
Cotransmission
 

Similar to Sympathomimetics

adrenergic agonists & antagonists
adrenergic agonists & antagonistsadrenergic agonists & antagonists
adrenergic agonists & antagonistsdrjawaria73
 
Adrenergic System.pptx
Adrenergic System.pptxAdrenergic System.pptx
Adrenergic System.pptxZainAliKhan17
 
Adrenergic agonists
Adrenergic agonistsAdrenergic agonists
Adrenergic agonistsLeul Mesfin
 
ANS-_Adrenergic_drugs-_Catecholamines.pdf
ANS-_Adrenergic_drugs-_Catecholamines.pdfANS-_Adrenergic_drugs-_Catecholamines.pdf
ANS-_Adrenergic_drugs-_Catecholamines.pdfSanjayaManiDixit
 
Class adrenergic drugs
Class adrenergic drugsClass adrenergic drugs
Class adrenergic drugsRaghu Prasada
 
adrenergicagonists-131016194637-phpapp02.pptx
adrenergicagonists-131016194637-phpapp02.pptxadrenergicagonists-131016194637-phpapp02.pptx
adrenergicagonists-131016194637-phpapp02.pptxayman255825
 
Adrenergic drugs.pptx
Adrenergic drugs.pptxAdrenergic drugs.pptx
Adrenergic drugs.pptxRushabh47
 
Adrenergic drugs part-II
Adrenergic drugs part-IIAdrenergic drugs part-II
Adrenergic drugs part-IIManoj Munde
 
IVMS Comprehensive -USMLE-type- Pharmacology-#1-2012 Examination-answers and ...
IVMS Comprehensive -USMLE-type- Pharmacology-#1-2012 Examination-answers and ...IVMS Comprehensive -USMLE-type- Pharmacology-#1-2012 Examination-answers and ...
IVMS Comprehensive -USMLE-type- Pharmacology-#1-2012 Examination-answers and ...Imhotep Virtual Medical School
 
Anti-Cholinergic drugs
Anti-Cholinergic drugsAnti-Cholinergic drugs
Anti-Cholinergic drugsEneutron
 
Adrenergic agonists essencial
Adrenergic agonists essencialAdrenergic agonists essencial
Adrenergic agonists essencialSebastian Fonque
 
sympathomimeticdrugsppt-210519082222 (1).pptx
sympathomimeticdrugsppt-210519082222 (1).pptxsympathomimeticdrugsppt-210519082222 (1).pptx
sympathomimeticdrugsppt-210519082222 (1).pptxMohammad Ahmed Khan
 
IVMS-Autonomic Pharmacology Formative Exam with Answer Key
IVMS-Autonomic Pharmacology Formative Exam with Answer KeyIVMS-Autonomic Pharmacology Formative Exam with Answer Key
IVMS-Autonomic Pharmacology Formative Exam with Answer KeyImhotep Virtual Medical School
 
sympathomimeticdrugsppt-210519082222.pdf
sympathomimeticdrugsppt-210519082222.pdfsympathomimeticdrugsppt-210519082222.pdf
sympathomimeticdrugsppt-210519082222.pdfJane756411
 
Adrenergic drugs
Adrenergic drugsAdrenergic drugs
Adrenergic drugsSahil Patil
 

Similar to Sympathomimetics (20)

adrenergic agonists & antagonists
adrenergic agonists & antagonistsadrenergic agonists & antagonists
adrenergic agonists & antagonists
 
Adrenergic System.pptx
Adrenergic System.pptxAdrenergic System.pptx
Adrenergic System.pptx
 
Adrenergic agonists
Adrenergic agonistsAdrenergic agonists
Adrenergic agonists
 
ANS-_Adrenergic_drugs-_Catecholamines.pdf
ANS-_Adrenergic_drugs-_Catecholamines.pdfANS-_Adrenergic_drugs-_Catecholamines.pdf
ANS-_Adrenergic_drugs-_Catecholamines.pdf
 
Class adrenergic drugs
Class adrenergic drugsClass adrenergic drugs
Class adrenergic drugs
 
adrenergicagonists-131016194637-phpapp02.pptx
adrenergicagonists-131016194637-phpapp02.pptxadrenergicagonists-131016194637-phpapp02.pptx
adrenergicagonists-131016194637-phpapp02.pptx
 
sympathomimetic
sympathomimeticsympathomimetic
sympathomimetic
 
Sympathomimetic
SympathomimeticSympathomimetic
Sympathomimetic
 
Adrenergic drugs.pptx
Adrenergic drugs.pptxAdrenergic drugs.pptx
Adrenergic drugs.pptx
 
Adrenergic drugs part-II
Adrenergic drugs part-IIAdrenergic drugs part-II
Adrenergic drugs part-II
 
Adrenergic drugs
Adrenergic drugsAdrenergic drugs
Adrenergic drugs
 
IVMS Comprehensive -USMLE-type- Pharmacology-#1-2012 Examination-answers and ...
IVMS Comprehensive -USMLE-type- Pharmacology-#1-2012 Examination-answers and ...IVMS Comprehensive -USMLE-type- Pharmacology-#1-2012 Examination-answers and ...
IVMS Comprehensive -USMLE-type- Pharmacology-#1-2012 Examination-answers and ...
 
Anti-Cholinergic drugs
Anti-Cholinergic drugsAnti-Cholinergic drugs
Anti-Cholinergic drugs
 
Sympathomimetic drugs
Sympathomimetic drugsSympathomimetic drugs
Sympathomimetic drugs
 
Adrenergic agonists essencial
Adrenergic agonists essencialAdrenergic agonists essencial
Adrenergic agonists essencial
 
sympathomimeticdrugsppt-210519082222 (1).pptx
sympathomimeticdrugsppt-210519082222 (1).pptxsympathomimeticdrugsppt-210519082222 (1).pptx
sympathomimeticdrugsppt-210519082222 (1).pptx
 
Adrenergic drugs
Adrenergic drugsAdrenergic drugs
Adrenergic drugs
 
IVMS-Autonomic Pharmacology Formative Exam with Answer Key
IVMS-Autonomic Pharmacology Formative Exam with Answer KeyIVMS-Autonomic Pharmacology Formative Exam with Answer Key
IVMS-Autonomic Pharmacology Formative Exam with Answer Key
 
sympathomimeticdrugsppt-210519082222.pdf
sympathomimeticdrugsppt-210519082222.pdfsympathomimeticdrugsppt-210519082222.pdf
sympathomimeticdrugsppt-210519082222.pdf
 
Adrenergic drugs
Adrenergic drugsAdrenergic drugs
Adrenergic drugs
 

More from UsmanKhalid135

Introduction to autonomic pharmacology
Introduction to autonomic pharmacologyIntroduction to autonomic pharmacology
Introduction to autonomic pharmacologyUsmanKhalid135
 
Cholinoceptor activating and cholinesterase-inhibiting drugs
Cholinoceptor activating and cholinesterase-inhibiting drugsCholinoceptor activating and cholinesterase-inhibiting drugs
Cholinoceptor activating and cholinesterase-inhibiting drugsUsmanKhalid135
 
Cholinoceptor Blockers
Cholinoceptor BlockersCholinoceptor Blockers
Cholinoceptor BlockersUsmanKhalid135
 
Adrenergic Receptor Blockers
Adrenergic Receptor BlockersAdrenergic Receptor Blockers
Adrenergic Receptor BlockersUsmanKhalid135
 
Pharmacokinetics Drug Distribution
Pharmacokinetics Drug DistributionPharmacokinetics Drug Distribution
Pharmacokinetics Drug DistributionUsmanKhalid135
 
Pharmacokinetics Drug Transportation
Pharmacokinetics  Drug TransportationPharmacokinetics  Drug Transportation
Pharmacokinetics Drug TransportationUsmanKhalid135
 
Introduction to Pharmacology
Introduction to PharmacologyIntroduction to Pharmacology
Introduction to PharmacologyUsmanKhalid135
 
Drugs Used in Hypertension
Drugs Used in HypertensionDrugs Used in Hypertension
Drugs Used in HypertensionUsmanKhalid135
 
Drugs used in Heart Failure
Drugs used in Heart FailureDrugs used in Heart Failure
Drugs used in Heart FailureUsmanKhalid135
 

More from UsmanKhalid135 (20)

Introduction to autonomic pharmacology
Introduction to autonomic pharmacologyIntroduction to autonomic pharmacology
Introduction to autonomic pharmacology
 
Cholinoceptor activating and cholinesterase-inhibiting drugs
Cholinoceptor activating and cholinesterase-inhibiting drugsCholinoceptor activating and cholinesterase-inhibiting drugs
Cholinoceptor activating and cholinesterase-inhibiting drugs
 
Cholinoceptor Blockers
Cholinoceptor BlockersCholinoceptor Blockers
Cholinoceptor Blockers
 
Adrenergic Receptor Blockers
Adrenergic Receptor BlockersAdrenergic Receptor Blockers
Adrenergic Receptor Blockers
 
Pharmacokinetics Drug Distribution
Pharmacokinetics Drug DistributionPharmacokinetics Drug Distribution
Pharmacokinetics Drug Distribution
 
Pharmacokinetics Drug Transportation
Pharmacokinetics  Drug TransportationPharmacokinetics  Drug Transportation
Pharmacokinetics Drug Transportation
 
Pharmacodynamics
PharmacodynamicsPharmacodynamics
Pharmacodynamics
 
Introduction to Pharmacology
Introduction to PharmacologyIntroduction to Pharmacology
Introduction to Pharmacology
 
Drug Elimination
Drug EliminationDrug Elimination
Drug Elimination
 
Bioavailability
BioavailabilityBioavailability
Bioavailability
 
Opioid Analgesics
Opioid AnalgesicsOpioid Analgesics
Opioid Analgesics
 
Drugs in Parkinsonism
Drugs in ParkinsonismDrugs in Parkinsonism
Drugs in Parkinsonism
 
Anti Pscychotic Drugs
Anti Pscychotic DrugsAnti Pscychotic Drugs
Anti Pscychotic Drugs
 
Anti Depressive Drugs
Anti Depressive DrugsAnti Depressive Drugs
Anti Depressive Drugs
 
Drugs Used in Hypertension
Drugs Used in HypertensionDrugs Used in Hypertension
Drugs Used in Hypertension
 
Drugs used in Heart Failure
Drugs used in Heart FailureDrugs used in Heart Failure
Drugs used in Heart Failure
 
Drugs Used In Angina
Drugs Used In AnginaDrugs Used In Angina
Drugs Used In Angina
 
Antiarrhythmic drugs
Antiarrhythmic drugsAntiarrhythmic drugs
Antiarrhythmic drugs
 
Nsaids, Acetaminophen
Nsaids, AcetaminophenNsaids, Acetaminophen
Nsaids, Acetaminophen
 
Coagulation Disorders
Coagulation DisordersCoagulation Disorders
Coagulation Disorders
 

Recently uploaded

On National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan FellowsOn National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan FellowsMebane Rash
 
Micro-Scholarship, What it is, How can it help me.pdf
Micro-Scholarship, What it is, How can it help me.pdfMicro-Scholarship, What it is, How can it help me.pdf
Micro-Scholarship, What it is, How can it help me.pdfPoh-Sun Goh
 
HMCS Vancouver Pre-Deployment Brief - May 2024 (Web Version).pptx
HMCS Vancouver Pre-Deployment Brief - May 2024 (Web Version).pptxHMCS Vancouver Pre-Deployment Brief - May 2024 (Web Version).pptx
HMCS Vancouver Pre-Deployment Brief - May 2024 (Web Version).pptxmarlenawright1
 
How to Create and Manage Wizard in Odoo 17
How to Create and Manage Wizard in Odoo 17How to Create and Manage Wizard in Odoo 17
How to Create and Manage Wizard in Odoo 17Celine George
 
Sociology 101 Demonstration of Learning Exhibit
Sociology 101 Demonstration of Learning ExhibitSociology 101 Demonstration of Learning Exhibit
Sociology 101 Demonstration of Learning Exhibitjbellavia9
 
Kodo Millet PPT made by Ghanshyam bairwa college of Agriculture kumher bhara...
Kodo Millet  PPT made by Ghanshyam bairwa college of Agriculture kumher bhara...Kodo Millet  PPT made by Ghanshyam bairwa college of Agriculture kumher bhara...
Kodo Millet PPT made by Ghanshyam bairwa college of Agriculture kumher bhara...pradhanghanshyam7136
 
How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17Celine George
 
Wellbeing inclusion and digital dystopias.pptx
Wellbeing inclusion and digital dystopias.pptxWellbeing inclusion and digital dystopias.pptx
Wellbeing inclusion and digital dystopias.pptxJisc
 
FSB Advising Checklist - Orientation 2024
FSB Advising Checklist - Orientation 2024FSB Advising Checklist - Orientation 2024
FSB Advising Checklist - Orientation 2024Elizabeth Walsh
 
Fostering Friendships - Enhancing Social Bonds in the Classroom
Fostering Friendships - Enhancing Social Bonds  in the ClassroomFostering Friendships - Enhancing Social Bonds  in the Classroom
Fostering Friendships - Enhancing Social Bonds in the ClassroomPooky Knightsmith
 
Python Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docxPython Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docxRamakrishna Reddy Bijjam
 
Google Gemini An AI Revolution in Education.pptx
Google Gemini An AI Revolution in Education.pptxGoogle Gemini An AI Revolution in Education.pptx
Google Gemini An AI Revolution in Education.pptxDr. Sarita Anand
 
How to setup Pycharm environment for Odoo 17.pptx
How to setup Pycharm environment for Odoo 17.pptxHow to setup Pycharm environment for Odoo 17.pptx
How to setup Pycharm environment for Odoo 17.pptxCeline George
 
ICT role in 21st century education and it's challenges.
ICT role in 21st century education and it's challenges.ICT role in 21st century education and it's challenges.
ICT role in 21st century education and it's challenges.MaryamAhmad92
 
Making communications land - Are they received and understood as intended? we...
Making communications land - Are they received and understood as intended? we...Making communications land - Are they received and understood as intended? we...
Making communications land - Are they received and understood as intended? we...Association for Project Management
 
Accessible Digital Futures project (20/03/2024)
Accessible Digital Futures project (20/03/2024)Accessible Digital Futures project (20/03/2024)
Accessible Digital Futures project (20/03/2024)Jisc
 
REMIFENTANIL: An Ultra short acting opioid.pptx
REMIFENTANIL: An Ultra short acting opioid.pptxREMIFENTANIL: An Ultra short acting opioid.pptx
REMIFENTANIL: An Ultra short acting opioid.pptxDr. Ravikiran H M Gowda
 
This PowerPoint helps students to consider the concept of infinity.
This PowerPoint helps students to consider the concept of infinity.This PowerPoint helps students to consider the concept of infinity.
This PowerPoint helps students to consider the concept of infinity.christianmathematics
 
UGC NET Paper 1 Mathematical Reasoning & Aptitude.pdf
UGC NET Paper 1 Mathematical Reasoning & Aptitude.pdfUGC NET Paper 1 Mathematical Reasoning & Aptitude.pdf
UGC NET Paper 1 Mathematical Reasoning & Aptitude.pdfNirmal Dwivedi
 
Unit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptxUnit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptxVishalSingh1417
 

Recently uploaded (20)

On National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan FellowsOn National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan Fellows
 
Micro-Scholarship, What it is, How can it help me.pdf
Micro-Scholarship, What it is, How can it help me.pdfMicro-Scholarship, What it is, How can it help me.pdf
Micro-Scholarship, What it is, How can it help me.pdf
 
HMCS Vancouver Pre-Deployment Brief - May 2024 (Web Version).pptx
HMCS Vancouver Pre-Deployment Brief - May 2024 (Web Version).pptxHMCS Vancouver Pre-Deployment Brief - May 2024 (Web Version).pptx
HMCS Vancouver Pre-Deployment Brief - May 2024 (Web Version).pptx
 
How to Create and Manage Wizard in Odoo 17
How to Create and Manage Wizard in Odoo 17How to Create and Manage Wizard in Odoo 17
How to Create and Manage Wizard in Odoo 17
 
Sociology 101 Demonstration of Learning Exhibit
Sociology 101 Demonstration of Learning ExhibitSociology 101 Demonstration of Learning Exhibit
Sociology 101 Demonstration of Learning Exhibit
 
Kodo Millet PPT made by Ghanshyam bairwa college of Agriculture kumher bhara...
Kodo Millet  PPT made by Ghanshyam bairwa college of Agriculture kumher bhara...Kodo Millet  PPT made by Ghanshyam bairwa college of Agriculture kumher bhara...
Kodo Millet PPT made by Ghanshyam bairwa college of Agriculture kumher bhara...
 
How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17
 
Wellbeing inclusion and digital dystopias.pptx
Wellbeing inclusion and digital dystopias.pptxWellbeing inclusion and digital dystopias.pptx
Wellbeing inclusion and digital dystopias.pptx
 
FSB Advising Checklist - Orientation 2024
FSB Advising Checklist - Orientation 2024FSB Advising Checklist - Orientation 2024
FSB Advising Checklist - Orientation 2024
 
Fostering Friendships - Enhancing Social Bonds in the Classroom
Fostering Friendships - Enhancing Social Bonds  in the ClassroomFostering Friendships - Enhancing Social Bonds  in the Classroom
Fostering Friendships - Enhancing Social Bonds in the Classroom
 
Python Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docxPython Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docx
 
Google Gemini An AI Revolution in Education.pptx
Google Gemini An AI Revolution in Education.pptxGoogle Gemini An AI Revolution in Education.pptx
Google Gemini An AI Revolution in Education.pptx
 
How to setup Pycharm environment for Odoo 17.pptx
How to setup Pycharm environment for Odoo 17.pptxHow to setup Pycharm environment for Odoo 17.pptx
How to setup Pycharm environment for Odoo 17.pptx
 
ICT role in 21st century education and it's challenges.
ICT role in 21st century education and it's challenges.ICT role in 21st century education and it's challenges.
ICT role in 21st century education and it's challenges.
 
Making communications land - Are they received and understood as intended? we...
Making communications land - Are they received and understood as intended? we...Making communications land - Are they received and understood as intended? we...
Making communications land - Are they received and understood as intended? we...
 
Accessible Digital Futures project (20/03/2024)
Accessible Digital Futures project (20/03/2024)Accessible Digital Futures project (20/03/2024)
Accessible Digital Futures project (20/03/2024)
 
REMIFENTANIL: An Ultra short acting opioid.pptx
REMIFENTANIL: An Ultra short acting opioid.pptxREMIFENTANIL: An Ultra short acting opioid.pptx
REMIFENTANIL: An Ultra short acting opioid.pptx
 
This PowerPoint helps students to consider the concept of infinity.
This PowerPoint helps students to consider the concept of infinity.This PowerPoint helps students to consider the concept of infinity.
This PowerPoint helps students to consider the concept of infinity.
 
UGC NET Paper 1 Mathematical Reasoning & Aptitude.pdf
UGC NET Paper 1 Mathematical Reasoning & Aptitude.pdfUGC NET Paper 1 Mathematical Reasoning & Aptitude.pdf
UGC NET Paper 1 Mathematical Reasoning & Aptitude.pdf
 
Unit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptxUnit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptx
 

Sympathomimetics

  • 2. Sympathomimetics O A drug that mimics stimulation of the sympathetic autonomic nervous system.
  • 4. Mode of Action O Sympathomimetic agonists may directly activate their adrenoceptors, or they may act indirectly to increase the concentration of endogenous catecholamine transmitter in the synapse.
  • 5. Types of adrenoceptors, some of the peripheral tissues in which they are found, and their major effects
  • 6. CHEMISTRY & PHARMACOKINETICS O The endogenous adrenoceptor agonists (epinephrine, norepinephrine, and dopamine) are catecholamines and are rapidly metabolized by COMT and MAO. O If used as drugs, these adrenoceptor agonists are relatively inactive by the oral route and must be given parenterally. O Short duration of action.
  • 7. MECHANISMS OF ACTION O A. Alpha-Receptor Effects: Alpha- receptor effects are mediated primarily by the trimeric coupling protein Gq. When Gq is activated, the alpha moiety of this protein activates the enzyme phospholipase C, resulting in the release of inositol-1,4,5-trisphosphate (IP3) and diacylglycerol (DAG) from membrane lipids.
  • 8. B. Beta-Receptor Effects O All β receptors (β1, β2, and β3) stimulate adenylyl cyclase via the coupling protein Gs, which leads to an increase in cyclic adenosine monophosphate (cAMP) concentration in the cell.
  • 9. C. Dopamine-Receptor Effects O Dopamine D1 receptors activate adenylyl cyclase via Gs and increase cAMP in neurons and vascular smooth muscle. O Dopamine D2 receptors are more important in the brain but probably also play a significant role as presynaptic receptors on peripheral nerves. O These receptors reduce the synthesis of cAMP via Gi.
  • 10. ORGAN SYSTEM EFFECTS O A. Central Nervous System: Sympathomimetics that do enter the CNS (eg, amphetamines, cocaine) have a spectrum of stimulant effects, beginning with mild alerting or reduction of fatigue and progressing to anorexia, euphoria, and insomnia. O Repeated dosing of amphetamines results in the rapid development of tolerance and dependence. O Very high doses of amphetamines lead to marked anxiety or aggressiveness, paranoia, and, less commonly, seizures. O Overdoses of cocaine very commonly result in seizures.
  • 11. B. Eye O The smooth muscle of the pupillary dilator responds to topical phenylephrine and similar α agonists with contraction and mydriasis. O Accommodation is not significantly affected.
  • 12. C. Bronchi O The smooth muscle of the bronchi relaxes markedly in response to β2 agonists, eg, isoproterenol and albuterol. These agents are the most efficacious and reliable drugs for reversing bronchospasm.
  • 13. D. Gastrointestinal Tract O The gastrointestinal tract is well endowed with both α and β receptors, located both on smooth muscle and on neurons of the enteric nervous system. O Activation of either α or β receptors leads to relaxation of the smooth muscle. Alpha2 agonists may also decrease salt and water secretion into the intestine.
  • 14. E. Genitourinary Tract O The genitourinary tract contains α receptors in the bladder trigone and sphincter area; these receptors mediate contraction of the sphincter. O In men, α1 receptors mediate prostatic smooth muscle contraction. O Sympathomimetics are sometimes used to increase sphincter tone. O Beta2 agonists may cause significant uterine relaxation in pregnant women near term, but the doses required also cause significant tachycardia.
  • 15. F. Vascular System O Different vascular beds respond differently, depending on their dominant receptor type: O 1. Alpha1 agonists— O Alpha1 agonists (eg, phenylephrine) contract vascular smooth muscle, especially in skin and splanchnic blood vessels, and increase peripheral vascular resistance and venous pressure. Because these drugs increase blood pressure, they often evoke a compensatory reflex bradycardia.
  • 16. O 2. Alpha2 agonists— O Alpha2 agonists (eg, clonidine) cause vasoconstriction when administered intravenously or topically (eg, as a nasal spray), but when given orally they accumulate in the CNS and reduce sympathetic outflow and blood pressure.
  • 17. O 3. Beta agonists—Beta2 agonists (eg, albuterol, metaproterenol, terbutaline) and nonselective β agonists (eg, isoproterenol) cause significant reduction in arteriolar tone in the skeletal muscle vascular bed and can reduce peripheral vascular resistance and arterial blood pressure. O Beta1 agonists have relatively little effect on vessels.
  • 18. O 4. Dopamine— O Dopamine causes vasodilation in the splanchnic and renal vascular beds by activating D1 receptors. O This effect can be useful in the treatment of renal failure associated with shock. O At higher doses, dopamine activates β receptors in the heart and elsewhere; at still higher doses, α receptors are activated.
  • 19. G.Heart O The heart is well supplied with β1 and β2 receptors. O The β1 receptors predominate in some parts of the heart; both β1 and β2 receptors mediate increased rate of cardiac pacemakers (normal and abnormal), increased atrioventricular node conduction velocity, and increased cardiac force.
  • 20. Net Cardiovascular Actions O Sympathomimetics with both α and β1 effects (eg, norepinephrine) may cause a reflex increase in vagal outflow because they increase blood pressure and evoke the baroreceptor reflex. O This reflex vagal effect may dominate any direct beta effects on the heart rate, so that a slow infusion of norepinephrine typically causes increased blood pressure and bradycardia . O If the reflex is blocked (eg, by a ganglion blocker or antimuscarinic drug), norepinephrine will cause a direct β1- mediated tachycardia.
  • 21. Metabolic and Hormonal Effects O Beta1 agonists increase renin secretion. O Beta2 agonists increase insulin secretion. O All β agonists appear to stimulate lipolysis via the β3 receptor.
  • 22. CLINICAL USES A. Anaphylaxis O Epinephrine is the drug of choice for the immediate treatment of anaphylactic shock. B. Central Nervous System O The phenylisopropylamines such as amphetamine are widely used and abused for their CNS effects. Legitimate indications include narcolepsy and, with appropriate adjuncts, weight reduction. O Cocaine is abused for its mood-elevating effect. These drugs have a high addiction liability.
  • 23. C. Eye O The α agonists, especially phenylephrine and tetrahydrozoline, are often used to reduce the conjunctival itching and congestion caused by irritation or allergy. O Newer α2 agonists are in current use for glaucoma and include apraclonidine and brimonidine.
  • 24. D. Bronchi O The β agonists, especially the β2- selective agonists, are drugs of choice in the treatment of acute asthmatic bronchoconstriction. O The short-acting β2-selective agonists (eg, albuterol, metaproterenol, terbutaline) are not recommended for prophylaxis, but they are safe and effective and may be lifesaving in the treatment of acute bronchospasm.
  • 25. E. Cardiovascular Applications 1. Conditions in which an increase in blood flow is desired: Beta1 agonist 2. Conditions in which a decrease in blood flow or increase in blood pressure is desired: Alpha1 agonists 3. Conditions in which acute cardiac stimulation is desired: Epinephrine
  • 26. O Genitourinary Tract: Beta2 agonists (ritodrine, terbutaline) are sometimes used to suppress premature labor, but the cardiac stimulant effect may be hazardous to both mother and fetus.
  • 27. TOXICITY O Excessive vasoconstriction O Cardiac arrhythmias O myocardial infarction O hemorrhagic stroke O Pulmonary edema or hemorrhage